577
Views
57
CrossRef citations to date
0
Altmetric
INVITED REVIEWS

Oxysterols as markers of neurological disease – a review

Pages 22-25 | Received 06 Aug 2008, Accepted 12 Nov 2008, Published online: 08 Jul 2009
 

Abstract

Cholesterol plays a crucial structural role in the brain and local synthesis covers almost all the requirements of the brain. To maintain homeostasis, the excess of cholesterol is converted into the more hydrophilic oxysterol 24S‐hydroxycholesterol by the neuron‐specific enzyme CYP46A1. About 99 % of the total excretion of this oxysterol by the brain occurs across the blood‐brain barrier directly into the bloodstream. Almost all the 24S‐hydroxycholesterol present in human circulation has a cerebral origin and its concentrations depend on the number of metabolically active neurons located in the grey matter of the brain. Neurodegeneration, with loss of neurons, and the subsequent brain atrophy are associated with significantly reduced concentrations of oxysterols. 24S‐Hydroxycholesterol can thus be used as a surrogate marker of brain atrophy in neurodegenerative diseases such as Alzheimer and multiple sclerosis. Less than 1 % of the total excretion of 24S‐hydroxycholesterol is via the cerebrospinal fluid. This small fraction appears to reflect neuronal damage and rate of neuronal loss rather than the total number of metabolically active neuronal cells. Patients with neurodegenerative disorders have thus been found to have increased concentrations of 24S‐hydroxycholesterol in cerebrospinal fluid, in parallel with decreased concentrations in the circulation. Compared with other available biomarkers in CSF, such as Total Tau, Phospo‐Tau and β42 amyloid, the 24S‐hydroxycholesterol appears to be the most sensitive biomarker in the evaluation of patients with cognitive impairment disease.

Acknowledgements

This work was supported by grants from the Swedish Science Council, Brain Power, Gamla Tjänarinnor Foundation and Stiftelsen Dementia, BLANCEFLOR Foundation Boncompagni‐Ludovisi nèe Bildt.

Declaration of interest: The author reports no conflicts of interest. The author alone is responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.